Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.2 |
mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |